DD. Richman, Antiretroviral activity of emtricitabine, a potent nucleoside reverse transcriptase inhibitor., in Antivir Ther, vol. 6, n. 2, giugno 2001, pp. 83-8, PMID 11491420.
LM. Bang, LJ. Scott, Emtricitabine: an antiretroviral agent for HIV infection., in Drugs, vol. 63, n. 22, 2003, pp. 2413-24; discussion 2425-6, PMID 14609348.
RG. Gish, NW. Leung; TL. Wright; H. Trinh; W. Lang; HA. Kessler; L. Fang; LH. Wang; J. Delehanty; A. Rigney; E. Mondou, Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection., in Antimicrob Agents Chemother, vol. 46, n. 6, giugno 2002, pp. 1734-40, PMID 12019083.
LH. Wang, AA. Wiznia; MH. Rathore; GE. Chittick; SS. Bakshi; PJ. Emmanuel; PM. Flynn, Pharmacokinetics and safety of single oral doses of emtricitabine in human immunodeficiency virus-infected children., in Antimicrob Agents Chemother, vol. 48, n. 1, gennaio 2004, pp. 183-91, PMID 14693538.
A. Ala, DT. Dieterich, Editorial comment: HIV and HBV coinfection--a coming-of-age in treatment strategies., in AIDS Read, vol. 14, n. 3, marzo 2004, pp. 134-5, PMID 15068001.
P. Barreiro, L. Martín-Carbonero; J. García-Samaniego, [Hepatitis B in patients with HIV infection]., in Enferm Infecc Microbiol Clin, 26 Suppl 7, maggio 2008, pp. 71-9, PMID 19100234.
C. Giaquinto, O. Rampon; M. Penazzato; F. Fregonese; A.De Rossi; R. D'Elia, Nucleoside and nucleotide reverse transcriptase inhibitors in children., in Clin Drug Investig, vol. 27, n. 8, 2007, pp. 509-31, PMID 17638393.